GO:0009986; C:cell surface; IDA:BHF-UCL
GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome
GO:0031012; C:extracellular matrix; IDA:MGI
GO:0005576; C:extracellular region; TAS:Reactome
GO:0005615; C:extracellular space; IBA:RefGenome
GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-KW
GO:0005125; F:cytokine activity; IDA:BHF-UCL
GO:0005109; F:frizzled binding; IPI:BHF-UCL
GO:0005110; F:frizzled-2 binding; IDA:MGI
GO:0019904; F:protein domain specific binding; IPI:UniProtKB
GO:0005102; F:receptor binding; IPI:MGI
GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
GO:0032148; P:activation of protein kinase B activity; IEA:Ensembl
GO:0001667; P:ameboidal cell migration; IMP:MGI
GO:0008595; P:anterior/posterior axis specification, embryo; IDA:BHF-UCL
GO:0009952; P:anterior/posterior pattern specification; IMP:MGI
GO:0003401; P:axis elongation; IMP:MGI
GO:0007411; P:axon guidance; IDA:UniProtKB
GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
GO:0051216; P:cartilage development; IEA:UniProtKB-KW
GO:0045165; P:cell fate commitment; IBA:RefGenome
GO:0016477; P:cell migration; IMP:MGI
GO:0007267; P:cell-cell signaling; TAS:MGI
GO:0034613; P:cellular protein localization; IMP:MGI
GO:0071277; P:cellular response to calcium ion; IEA:Ensembl
GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl
GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
GO:0071219; P:cellular response to molecule of bacterial origin; IDA:BHF-UCL
GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
GO:0060067; P:cervix development; IMP:MGI
GO:0090103; P:cochlea morphogenesis; IMP:MGI
GO:0060026; P:convergent extension; IMP:MGI
GO:0060029; P:convergent extension involved in organogenesis; IGI:MGI
GO:0007368; P:determination of left/right symmetry; IMP:MGI
GO:0046546; P:development of primary male sexual characteristics; IMP:MGI
GO:0048546; P:digestive tract morphogenesis; IMP:MGI
GO:0071542; P:dopaminergic neuron differentiation; IMP:MGI
GO:0042733; P:embryonic digit morphogenesis; IMP:MGI
GO:0030326; P:embryonic limb morphogenesis; IMP:MGI
GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
GO:0060750; P:epithelial cell proliferation involved in mammary gland duct elongation; IDA:MGI
GO:0001837; P:epithelial to mesenchymal transition; IEA:Ensembl
GO:0001736; P:establishment of planar polarity; IMP:MGI
GO:0060324; P:face development; IEA:Ensembl
GO:0001947; P:heart looping; IGI:MGI
GO:0071425; P:hematopoietic stem cell proliferation; IDA:MGI
GO:0007442; P:hindgut morphogenesis; IMP:MGI
GO:0048850; P:hypophysis morphogenesis; IMP:MGI
GO:0042472; P:inner ear morphogenesis; IDA:MGI
GO:0007254; P:JNK cascade; IDA:MGI
GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
GO:0060599; P:lateral sprouting involved in mammary gland duct morphogenesis; IDA:MGI
GO:0035108; P:limb morphogenesis; IMP:MGI
GO:0030324; P:lung development; IMP:MGI
GO:0008584; P:male gonad development; IMP:MGI
GO:0060744; P:mammary gland branching involved in thelarche; IDA:MGI
GO:0060638; P:mesenchymal-epithelial cell signaling; IMP:MGI
GO:0007494; P:midgut development; IMP:MGI
GO:0002009; P:morphogenesis of an epithelium; IMP:MGI
GO:0050919; P:negative chemotaxis; IGI:MGI
GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
GO:0048843; P:negative regulation of axon extension involved in axon guidance; IGI:MGI
GO:0030514; P:negative regulation of BMP signaling pathway; IMP:MGI
GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:MGI
GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IMP:MGI
GO:0072201; P:negative regulation of mesenchymal cell proliferation; IEA:Ensembl
GO:0060686; P:negative regulation of prostatic bud formation; IMP:MGI
GO:0051964; P:negative regulation of synapse assembly; IDA:BHF-UCL
GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
GO:0001843; P:neural tube closure; IGI:MGI
GO:0021915; P:neural tube development; IGI:MGI
GO:0048812; P:neuron projection morphogenesis; IDA:UniProtKB
GO:0038031; P:non-canonical Wnt signaling pathway via JNK cascade; IMP:BHF-UCL
GO:0021891; P:olfactory bulb interneuron development; IMP:UniProtKB
GO:0009887; P:organ morphogenesis; TAS:MGI
GO:0060021; P:palate development; IEA:Ensembl
GO:0003344; P:pericardium morphogenesis; IGI:MGI
GO:0061350; P:planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; IMP:MGI
GO:0061349; P:planar cell polarity pathway involved in cardiac right atrium morphogenesis; IMP:MGI
GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IMP:MGI
GO:0061347; P:planar cell polarity pathway involved in outflow tract morphogenesis; IMP:MGI
GO:0061354; P:planar cell polarity pathway involved in pericardium morphogenesis; IMP:MGI
GO:0061348; P:planar cell polarity pathway involved in ventricular septum morphogenesis; IMP:MGI
GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
GO:0061036; P:positive regulation of cartilage development; IDA:MGI
GO:0008284; P:positive regulation of cell proliferation; IDA:MGI
GO:2000049; P:positive regulation of cell-cell adhesion mediated by cadherin; IDA:MGI
GO:0030825; P:positive regulation of cGMP metabolic process; IEA:Ensembl
GO:0045080; P:positive regulation of chemokine biosynthetic process; IEA:Ensembl
GO:0002741; P:positive regulation of cytokine secretion involved in immune response; IEA:Ensembl
GO:0010595; P:positive regulation of endothelial cell migration; IEA:Ensembl
GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:MGI
GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
GO:0032729; P:positive regulation of interferon-gamma production; IMP:BHF-UCL
GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:BHF-UCL
GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
GO:2000484; P:positive regulation of interleukin-8 secretion; IDA:BHF-UCL
GO:0046330; P:positive regulation of JNK cascade; IMP:BHF-UCL
GO:0043507; P:positive regulation of JUN kinase activity; IDA:MGI
GO:0043032; P:positive regulation of macrophage activation; IEA:Ensembl
GO:0060907; P:positive regulation of macrophage cytokine production; IEA:Ensembl
GO:0045836; P:positive regulation of meiosis; IGI:MGI
GO:0002053; P:positive regulation of mesenchymal cell proliferation; IMP:MGI
GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB
GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
GO:0045778; P:positive regulation of ossification; IEA:Ensembl
GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IGI:MGI
GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IGI:MGI
GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
GO:0090037; P:positive regulation of protein kinase C signaling; IEA:Ensembl
GO:0001934; P:positive regulation of protein phosphorylation; IDA:MGI
GO:0010820; P:positive regulation of T cell chemotaxis; IEA:Ensembl
GO:0070245; P:positive regulation of thymocyte apoptotic process; IMP:MGI
GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IEA:Ensembl
GO:0036342; P:post-anal tail morphogenesis; IMP:MGI
GO:0090009; P:primitive streak formation; IGI:MGI
GO:0006468; P:protein phosphorylation; IGI:MGI
GO:0060762; P:regulation of branching involved in mammary gland duct morphogenesis; IDA:MGI
GO:0007165; P:signal transduction; TAS:MGI
GO:0001756; P:somitogenesis; IGI:MGI
GO:0060606; P:tube closure; IMP:MGI
GO:0003323; P:type B pancreatic cell development; IMP:MGI
GO:0060157; P:urinary bladder development; IMP:MGI
GO:0060065; P:uterus development; IMP:MGI
GO:0060068; P:vagina development; IMP:MGI
GO:0016055; P:Wnt signaling pathway; IGI:MGI
GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; IDA:BHF-UCL
GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IDA:MGI
GO:0042060; P:wound healing; IEA:Ensembl